Insufficient scRNA-seq data for expression of B3GALT1 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 43% ± 34% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 779.83 | 2557 / 2642 | 95% | 6.40 | 668 / 705 |
intestine | 77% | 262.33 | 743 / 966 | 27% | 0.74 | 141 / 527 |
muscle | 98% | 505.58 | 783 / 803 | 0% | 0 | 0 / 0 |
skin | 3% | 3.08 | 59 / 1809 | 68% | 5.48 | 320 / 472 |
breast | 55% | 91.41 | 254 / 459 | 5% | 0.13 | 54 / 1118 |
adrenal gland | 7% | 9.98 | 18 / 258 | 49% | 2.91 | 113 / 230 |
ovary | 16% | 14.92 | 28 / 180 | 32% | 1.22 | 136 / 430 |
thymus | 39% | 42.42 | 254 / 653 | 3% | 0.07 | 18 / 605 |
prostate | 32% | 42.07 | 79 / 245 | 5% | 0.13 | 27 / 502 |
spleen | 29% | 30.63 | 70 / 241 | 0% | 0 | 0 / 0 |
uterus | 10% | 16.22 | 17 / 170 | 18% | 0.87 | 84 / 459 |
stomach | 6% | 4.92 | 20 / 359 | 17% | 0.41 | 49 / 286 |
adipose | 17% | 16.99 | 205 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 13% | 11.73 | 41 / 328 | 1% | 0.03 | 2 / 178 |
lung | 4% | 5.06 | 26 / 578 | 7% | 0.21 | 86 / 1155 |
esophagus | 4% | 4.20 | 57 / 1445 | 6% | 0.13 | 11 / 183 |
blood vessel | 9% | 10.86 | 124 / 1335 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 8% | 0.17 | 40 / 504 |
liver | 0% | 0 | 0 / 226 | 8% | 0.38 | 32 / 406 |
kidney | 0% | 0 | 0 / 89 | 6% | 0.19 | 54 / 901 |
eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
heart | 0% | 0.40 | 4 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030259 | Biological process | lipid glycosylation |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0006682 | Biological process | galactosylceramide biosynthetic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0008499 | Molecular function | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO_0047275 | Molecular function | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity |
Gene name | B3GALT1 |
Protein name | Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1) |
Synonyms | |
Description | FUNCTION: Beta-1,3-galactosyltransferase that transfers galactose from UDP-alpha-D-galactose to substrates with a terminal beta-N-acetylglucosamine (beta-GlcNAc) residue. Involved in the biosynthesis of the carbohydrate moieties of glycolipids and glycoproteins. Inactive towards substrates with terminal alpha-N-acetylglucosamine (alpha-GlcNAc) or alpha-N-acetylgalactosamine (alpha-GalNAc) residues. . |
Accessions | Q9Y5Z6 ENST00000392690.4 |